Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-07

Clinical Trial Update: Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating Modified Huang-Lian-Jie-Du Decoction for atopic dermatitis in children; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modified Huang-Lian-Jie-Du Decoction

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: UNKNOWN